Barinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 9,100 shares, a decline of 52.1% from the April 30th total of 19,000 shares. Based on an average daily volume of 22,300 shares, the short-interest ratio […]